Showing results (21-30 of 134) with videos related to
Sort By:
Pageof 14
The AAPS Journal|October 4, 2017
Investigating Oral Absorption of Carbamazepine in Pediatric PopulationsPhilip Kohlmann, Cordula Stillhart, Martin Kuentz, et al.Drug Discovery Today. Technologies|December 17, 2016
Translational PK/PD modeling to increase probability of success in drug discovery and early developmentThierry Lavé, Antonello Caruso, Neil Parrott, et al.Clinical Pharmacology and Therapeutics|April 28, 2025
Prospective DDI Risk Assessment of Vicasinabin with PBPK Modeling by Integrating In Vitro DataKenichi Umehara, Neil Parrott, Andreas Günther, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 13, 2005
A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog studyMartin Kuentz, Sonja Nick, Neil Parrott, et al.Clinical Pharmacokinetics|April 28, 2006
A novel strategy for physiologically based predictions of human pharmacokineticsHannah M Jones, Neil Parrott, Karin Jorga, et al.CPT: Pharmacometrics & Systems Pharmacology|May 18, 2022
Introduction of an artificial neural network-based method for concentration-time predictionsDominic Stefan Bräm, Neil Parrott, Lucy Hutchinson, et al.Clinical Pharmacokinetics|November 23, 2006
Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modellingHannah M Jones, Neil Parrott, Gerd Ohlenbusch, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 5, 2012
Application of PBPK modeling to predict human intestinal metabolism of CYP3A substrates - an evaluation and case study using GastroPlusAki T Heikkinen, Guillaume Baneyx, Antonello Caruso, et al.Proteomics. Clinical Applications|February 14, 2015
The role of quantitative ADME proteomics to support construction of physiologically based pharmacokinetic models for use in small molecule drug developmentAki T Heikkinen, Floriane Lignet, Paul Cutler, et al.Birth Defects Research. Part B, Developmental and Reproductive Toxicology|May 26, 2016
Preclinical Reproductive and Developmental Toxicity Profile of a Glycine Transporter Type 1 (Glyt1) InhibitorPaul Barrow, Neil Parrott, Daniela Alberati, et al.Pageof 14